Pharmacophore mapping and electronic feature analysis for a series of nitroaromatic compounds with antitubercular activity.
A five point pharmacophore was generated using PHASE for a series of nitroaromatic compounds and their congeners as antitubercular agents. The generated pharmacophore yielded significant 3D-QSAR model with r(2) of 0.890 for a training set of 92 molecules. The model also showed excellent predictive power with correlation coefficient Q(2) of 0.857 for a test set of 31 compounds. The pharmacophore indicated that presence of a nitro group, a piperazine moiety, one aromatic ring feature and two acceptor features are necessary for potent antitubercular activity. The pharmacophore was supported by electronic property analysis using density functional theory (DFT) at B3LYP/3-21*G level. Molecular electrostatic profile of the compounds was consistent with the generated pharmacophore model, particularly appearance of localized negative potential regions near both the oxygen atoms of nitro group extending laterally to the isoxazole ring system/amide bond in the most active compounds. Calculated data further revealed that all active compounds have smaller LUMO energies located over the nitro group, furan ring, and isoxazole ring/amide bond attached to it. Higher negative values of LUMO energies concentrated over the nitro group are indicative of the electron acceptor capacity of the compounds, suggesting that these compounds are prodrugs and must be activated by TB-nitroreductase. The results obtained from this study should aid in efficient design and development of nitroaromatic compounds as antitubercular agents.
Tawari
Nilesh R
NR
Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, University of Mumbai, Matunga (E), Mumbai 400019, India.
Degani
Mariam S
MS
D000995:Antitubercular Agents / Q000737:chemistry* / Q000494:pharmacology; D003198:Computer Simulation; D008826:Microbial Sensitivity Tests; D008956:Models, Chemical; D008958:Models, Molecular; D015394:Molecular Structure; D009169:Mycobacterium tuberculosis / Q000201:enzymology; D009574:Nitro Compounds / Q000737:chemistry* / Q000494:pharmacology; D009601:Nitroreductases / Q000037:antagonists & inhibitors / Q000737:chemistry; D011355:Prodrugs / Q000737:chemistry* / Q000494:pharmacology; D021281:Quantitative Structure-Activity Relationship; D055672:Static Electricity; D013237:Stereoisomerism
D000995:Antitubercular Agents; D009574:Nitro Compounds; D011355:Prodrugs; D009601:Nitroreductases